IQVIA Holdings Inc.
IQV
Rang în acțiuni
#556
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical... IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Preț acțiune
$267.50
Ultima sincronizare: 2026-10-20
Capitalizare de piață
$44.03B
Schimbare (1 zi)
0.62%
Schimbare (1 an)
22.33%
Țară
US
Tranzacționează IQVIA Holdings Inc. (IQV)
Categorie
Healthcare
Raport P/E pentru IQVIA Holdings Inc. (IQV)
Raport P/E la data de October 2026 TTM: 32.24
Conform celor mai recente rapoarte financiare și prețului acțiunilor IQVIA Holdings Inc., raportul P/E actual (TTM) este 32.24. La sfârșitul anului 2024, compania avea un P/E de 25.95.
Istoricul raportului P/E pentru IQVIA Holdings Inc. din 2010 până în 2026
Raportul P/E la sfârșitul fiecărui an
| An | Raport P/E | Schimbă |
|---|---|---|
| 2026 (TTM) | 32.24 | 13.18% |
| 2025 | 28.49 | 9.80% |
| 2024 | 25.95 | -17.14% |
| 2023 | 31.32 | -11.11% |
| 2022 | 35.23 | -36.98% |
| 2021 | 55.90 | -54.50% |
| 2020 | 122.85 | -22.16% |
| 2019 | 157.83 | 72.74% |
| 2018 | 91.37 | 460.90% |
| 2017 | 16.29 | -83.48% |
| 2016 | 98.60 | 351.94% |
| 2015 | 21.82 | 3.19% |
| 2014 | 21.14 | -16.72% |
| 2013 | 25.39 | -14.68% |
| 2012 | 29.76 | 36.17% |
| 2011 | 21.85 | -33.58% |
| 2010 | 32.90 | 0.00% |
Raportul P/E pentru companii similare sau concurenți
| Companie | P/E Ratio | Diferență P/E Ratio | Țara |
|---|---|---|---|
| 36.15 | 12.13% |
US
|
|
| 39.77 | 23.35% |
US
|
|
| -290.26 | -1,000.17% |
US
|
|
| - | - |
CN
|
|
| 34.18 | 6.02% |
US
|
Cum interpretezi un P/E ratio?
Raportul Preț/Câștig (P/E Ratio) măsoară relația dintre prețul acțiunii unei companii și câștigul pe acțiune.
Un P/E scăzut dar pozitiv indică o companie cu profituri mari în raport cu evaluarea actuală și ar putea fi subevaluată. Un P/E negativ mare (aproape de 0) indică pierderi majore.
Companiile cu un P/E peste 30 sau negativ sunt considerate în general „acțiuni de creștere”, adică investitorii se așteaptă la creștere sau profitabilitate viitoare.
Companiile cu un P/E pozitiv sub 10 sunt considerate „acțiuni de valoare”, adică sunt deja profitabile, dar cu șanse mici de creștere suplimentară.